DarioHealth Corp.
DRIO Healthcare Health Information Services
DarioHealth Corp.’s revenue for fiscal 2025 (year ended December 2025) was $22.4 million, down 17.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.58%, EPS grew 76.4%, free cash flow was flat and total debt rose 1.85%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow DRIO
DarioHealth Corp. (DRIO) EV/Sales
As of 16 October 2026, DarioHealth Corp. (DRIO) trades at a EV/Sales of 3.5×. Over the past ten years it has ranged from −5.7× (March 2016) to 24.8× (June 2021); the current reading is higher than 79% of that period. That is above the Health Information Services industry median of 2.6× and in line with the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.7× | 87.24% |
| FY2024 | 1.4× | (25.83%) |
| FY2023 | 1.9× | (33.25%) |
| FY2022 | 2.9× | (66.85%) |
| FY2021 | 8.7× | 16.34% |
| FY2020 | 7.5× | — |
| FY2019 | −0.7× | — |
| FY2018 | −1.4× | — |
| FY2017 | −0.6× | — |
| FY2016 | −0.2× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 4.2× | 21.48% |
| Mar 2026 | 3.5× | 29.42% |
| Dec 2025 | 2.7× | 5.18% |
| Sep 2025 | 2.6× | 33.78% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BEAT HeartBeam, Inc. compare | n/m |
| DH Definitive Healthcare Corp. compare | 0.4× |
| LFMD LifeMD, Inc. compare | 0.5× |
| HCAT Health Catalyst, Inc. compare | 0.6× |
| CCLD CareCloud, Inc. compare | 0.8× |
| OPRX OptimizeRx Corp. compare | 1.6× |
| RNLXY Renalytix plc - Sponsored ADR compare | 2.5× |
| DRIO DarioHealth Corp. | 3.5× |
| ONMD OneMedNet Corporation compare | 18.2× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)